Urinary RNA Testing Could Avoid Unnecessary Prostate Biopsies
Combined urinary testing for PCA3 and TMPRSS2:ERG (T2:ERG) RNA can help avoid unnecessary biopsies while maintaining ability to detect aggressive... Read More
Combined urinary testing for PCA3 and TMPRSS2:ERG (T2:ERG) RNA can help avoid unnecessary biopsies while maintaining ability to detect aggressive... Read More
Active surveillance can yield excellent results in carefully selected younger men with prostate cancer, according to a new study. A... Read More
The addition of custirsen to docetaxel and prednisone failed to improve overall survival among patients with metastatic castration-resistant prostate cancer... Read More
Men who receive testosterone replacement therapy (TRT) had an increased rate of favorable-risk prostate cancer compared to those who did... Read More
“Liquid biopsy” analyses of circulating tumor DNA (ctDNA) from blood samples potentially reveal prognostic information about metastatic castration-resistant prostate cancer... Read More
Vascular-targeted photodynamic therapy with padeliporfin was significantly better than active surveillance over a 2-year period in men with low-risk localized... Read More
Long-term follow-up of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) confirmed earlier results showing no reduction in... Read More
The use of radiotherapy (RT) was associated with an overall survival benefit in patients with prostate cancer and lymph node... Read More
A new study showed that a 24-gene signature can predict outcomes following postoperative radiotherapy (RT) in patients with prostate adenocarcinoma... Read More
Prostate-specific antigen (PSA) failure in men with localized, intermediate-, or high-risk prostate cancer was associated with increased all-cause mortality in... Read More